-
Annual General Meeting
Alzbeta Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
-
Balance Sheet
Progress on Alzbeta Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
-
Director Appointment
Shiv Kumar Tiwari was appointed as a Director was appointed as a Director on 27 Jan 2017 & has been associated with this company since 8 years 11 months . was recorded as a recent event.
-
Director Appointment
The activity Sharwan Kumar was appointed as a Director was appointed as a Director on 27 Jan 2017 & has been associated with this company since 8 years 11 months . was completed.
-
Company Incorporation
Progress on Alzbeta Pharmaceuticals Private Limited was registered on 27 Jan 2017 with Roc Delhi & aged 8 years 11 months as per MCA records. was documented.
Alzbeta Pharmaceuticals Private Limited - Company Profile
Alzbeta Pharmaceuticals Private Limited, a active private limited company, was established on 27 January 2017 in New Delhi, Delhi, India. Engaging in retailers within the trade sector, it holds CIN: U51909DL2017PTC311099. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shiv Kumar Tiwari (Director), Sharwan Kumar (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No. 43, Block-A, Mange Ram Park, Landmark Near Shukar Bazar Road,, New Delhi, Delhi, 110086.
Company Details
- CIN/LLPIN
U51909DL2017PTC311099
- Registration Number
311099
- Incorporation Date
27 January 2017
- Authorized Capital
₹1.00 M
- Paid-Up Capital
₹0.10 M
- ROC Code
Roc Delhi
-
Listing Status
Unlisted
- Company Status
Active
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shiv Kumar Tiwari | Director | 27 Jan 2017 | Current |
| Sharwan Kumar | Director | 27 Jan 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alzbeta Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
In 2017, Alzbeta Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
-
Promoters: 92.83%
-
Public: 4.10%
-
Others: 3.07%
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
Unlock and access historical data on people associated with Alzbeta Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Alzbeta Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alzbeta Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
What is the CIN of Alzbeta Pharmaceuticals Private Limited?
The CIN of Alzbeta Pharmaceuticals Private Limited is U51909DL2017PTC311099.
Where is Alzbeta Pharmaceuticals Private Limited headquartered?
Alzbeta Pharmaceuticals Private Limited is headquartered at House No. 43, Block-A, Mange Ram Park, Landmark Near Shukar Bazar Road,, New Delhi, Delhi, 110086.
When was Alzbeta Pharmaceuticals Private Limited incorporated?
Alzbeta Pharmaceuticals Private Limited was incorporated on 27 January 2017.
Who are the current directors of Alzbeta Pharmaceuticals Private Limited?
The current directors of Alzbeta Pharmaceuticals Private Limited are
What is the primary industry of Alzbeta Pharmaceuticals Private Limited?
The primary industry of Alzbeta Pharmaceuticals Private Limited is Trade.
Is Alzbeta Pharmaceuticals Private Limited a listed company?
Alzbeta Pharmaceuticals Private Limited is unlisted.
What is the capital structure of Alzbeta Pharmaceuticals Private Limited?
The authorized capital of Alzbeta Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
What is the compliance status of Alzbeta Pharmaceuticals Private Limited?
The compliance status of Alzbeta Pharmaceuticals Private Limited is Compliant.
+91-XXXXXXXXXX